Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Immunosuppression

  • Single cell transcriptomic dissection of virus induced immunopathology in interferon gamma receptor null mice
    L Yang, I Angelidis, L Heumos, M Ansari, S Zhou, C Mayr, L Simon, M Strunz, F Theis, H Adler, H Schiller
    European Respiratory Journal Sep 2022, 60 (suppl 66) LSC-0036; DOI: 10.1183/13993003.congress-2022.LSC-0036
  • Safety of oral Nirmatrelvir plus Ritonavir in Lung transplant recipients
    O Straichman, L Fridkin, I Bakal, D Shitenberg, Y Shostak, M Heching, S Amor, D Rosengarten, Y Barac, Y Peysakhovich, A Atamna, B Pertzov, M Kramer
    European Respiratory Journal Sep 2022, 60 (suppl 66) 4696; DOI: 10.1183/13993003.congress-2022.4696
  • Critical COVID-19 Associated Pulmonary Mucormycosis (CAPM): The underreported life-threatening spectrum of the Mucormycosis epidemic
    S Bansal, H Kalpakam, P Thakare, R Mehta
    European Respiratory Journal Sep 2022, 60 (suppl 66) 3705; DOI: 10.1183/13993003.congress-2022.3705
  • Serological response following second and third SARS-CoV-2 vaccines in lung transplant recipients
    E Bárczi, V Varga, A Nagy, N Eszes, Z Jáky-Kováts, V Müller, A Bohacs
    European Respiratory Journal Sep 2022, 60 (suppl 66) 3859; DOI: 10.1183/13993003.congress-2022.3859
  • Evolution of fibrotic interstitial lung diseases (ILD) after COVID-19
    M Ramos Martins, M Serino, B Martins, I Carvalho, C Valente, M Barbosa, C Cascais-Costa, M Alves, A Terras-Alexandre, N Melo, P Caetano-Mota, H Novais-Bastos, A Morais
    European Respiratory Journal Sep 2022, 60 (suppl 66) 4172; DOI: 10.1183/13993003.congress-2022.4172
  • A retrospective cohort study to investigate the diagnostic yield of bronchoscopy with bronchoalveolar lavage in highly immunocompromised adult patients
    D AlAbdulhadi, A Aljishi, G Alabbadi, M H Khalafallah, Z Almusa, R Abdulqawi
    European Respiratory Journal Sep 2022, 60 (suppl 66) 3180; DOI: 10.1183/13993003.congress-2022.3180
  • Fungal colonisation in lung transplant recipients: A retrospective study from India
    O Tisekar, M M Lalani, V Rahulan, S K Ravipati, U Shah, P Dutta, S Attawar
    European Respiratory Journal Sep 2022, 60 (suppl 66) 3372; DOI: 10.1183/13993003.congress-2022.3372
  • Chronic hypersensitivity pneumonitis - how to predict the treatment success?
    K B Lewandowska, I Baranska, M Sobiecka, P Radwan-Rohrenschef, M Dybowska, M Franczuk, A Rozy, A Skoczylas, I Bestry, J Kus, W Tomkowski, M Szturmowicz
    European Respiratory Journal Sep 2022, 60 (suppl 66) 3131; DOI: 10.1183/13993003.congress-2022.3131
  • Microbiological profile of post covid patients admitted in tertiary care center with pulmonary infections.
    D Muthreja
    European Respiratory Journal Sep 2022, 60 (suppl 66) 3140; DOI: 10.1183/13993003.congress-2022.3140
  • Similar Programmed Death Ligand 1 expression profile in COPD and NSCLC structural and immune cells
    R Esposito, D Mirra, G Spaziano, E Cione, L Gallelli, A Capuozzo, C Santoriello, M Polverino, B D'Agostino, F Polverino
    European Respiratory Journal Sep 2022, 60 (suppl 66) 3466; DOI: 10.1183/13993003.congress-2022.3466

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 37
  • Acute lung injury and critical care (83)
  • Asthma and allergy (674)
  • CF and non-CF bronchiectasis (288)
  • COPD and smoking (920)
  • Epidemiology, occupational and environmental lung disease (220)
  • Genetics (61)
  • Interstitial and orphan lung disease (517)
  • Lung biology and experimental studies (321)
  • Lung cancer (285)
  • Lung imaging (45)
  • Lung structure and function (303)
  • Mechanisms of lung disease (145)
  • Paediatric pulmonology (396)
  • Pulmonary pharmacology and therapeutics (142)
  • Pulmonary vascular disease (532)
  • Respiratory clinical practice (174)
  • Respiratory infections and tuberculosis (986)
  • Sleep medicine (272)

Custom Text goes here

  • Most Read
  • Twitter
Loading
  • 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
  • Pulsus paradoxus
  • ERS/ATS technical standard on interpretive strategies for routine lung function tests
  • ERS clinical practice guidelines on treatment of sarcoidosis
  • Lung volumes and forced ventilatory flows
More...

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society